Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine FDT vs Subutex Preference Study
NCT01075971Phase 2Completed
- Sponsor
- Indivior
- Start
- Sep 2005
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by Indivior. Started Sep 2005; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01075971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075971.